Music |
Video |
Movies |
Chart |
Show |
MDS clinical trials: the European effort (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View | |
2022 Scientific Symposium Highlights for Patients: Treatments for MDS and Secondary AML (AAMDSIF) View | |
How could venetoclax combinations improve outcome in high-risk MDS (MDS Hub) View | |
Immune checkpoint inhibitors in MDS and AML (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View | |
The i4MDS consortium and immune monitoring in MDS (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View | |
An update on the phase 3 MDS-005 trial (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View | |
BCEEEF 2011: Treatment of myelodysplastic syndrome: Expert Roundtable. (ecancer) View | |
Lower-risk MDS in 2021: luspatercept, imetelstat u0026 roxadustat (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View | |
Why is TIM3 a good target for treating patients with high-risk MDS (MDS Hub) View | |
How Is the MDS Patient Experience Measured (Blood Cancers Today) View |